Your browser doesn't support javascript.
loading
The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country.
Toy, Mehlika; Onder, Fatih Oguz; Idilman, Ramazan; Kabacam, Gokhan; Richardus, Jan Hendrik; Bozdayi, Mithat; Akdogan, Meral; Kuloglu, Zarife; Kansu, Aydan; Schalm, Solko; Yurdaydin, Cihan.
  • Toy M; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 50, 3000 CA, Rotterdam, The Netherlands, m.toy@erasmusmc.nl.
Eur J Health Econ ; 13(5): 663-76, 2012 Oct.
Article en En | MEDLINE | ID: mdl-22815098
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis B Crónica / Renta Tipo de estudio: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País como asunto: Asia Idioma: En Año: 2012 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis B Crónica / Renta Tipo de estudio: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País como asunto: Asia Idioma: En Año: 2012 Tipo del documento: Article